Healthcare Industry News: Stent-Graft
News Release - April 6, 2010
Bolton Medical Obtains CE Mark for New Relay NBS With Plus Delivery SystemSUNRISE, FL--(HSMN NewsFeed) - Bolton Medical announced today that it has obtained a CE Mark for its newly improved Relay NBS (Non-Bare Stent) Thoracic Stent-Graft with Plus Delivery System. The new system allows for improved covered-graft apposition in tightly curved aortas and greater expansion control in larger diameter anatomies during the treatment of complex thoracic aortic aneurysms.
The Relay NBS Thoracic Stent-Graft with Plus Delivery System was CE marked in March 2010 and will be available in Europe and all countries that recognize CE mark certification. It will be launched at the International Charing Cross Annual Symposium in London at Bolton Medical Symposium on Monday, April 12, 2010 from 12:30-1:30pm.
The Relay NBS Thoracic Stent-Graft with Plus Delivery System represents the latest innovation for the Relay aortic product line and is part of Bolton Medical's ongoing commitment to develop the highest quality, most innovative technologies for aortic repair.
Relay and Relay NBS Endovascular Stent-Grafts are indicated for the treatment of main thoracic aortic pathologies such as aneurysms, penetrating ulcers, pseudoaneurysms and intramural hematomas in adult patients. As of today, more than 3000 patients have been treated world-wide with Relay and Relay NBS Stent-Grafts.
Bolton Medical is a private company, with European operations based in Barcelona, Spain, and U.S. operations in Sunrise, Florida. Bolton Medical is a wholly-owned subsidiary of the Werfen Life Group, a diverse manufacturer and supplier of products for the medical industry. www.boltonmedical.com
Source: Bolton Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.